CLINITECH LABORATORY LIMITED has reported on the utilization of funds raised from its public issue (IPO), which totaled INR 5.78 Cr.

The company confirmed that there is no deviation or variation in how these funds are being used compared to the original plan.

INR 5.28 Cr has been utilized towards its stated objectives, including the expansion of diagnostic centers, general corporate purposes, and issue-related expenses.

This update reassures investors that the funds are being deployed as intended, aligning with the company's initial IPO goals.